| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Silverback Therapeutics, Inc. | Chief Financial Officer | Common Stock | 69.2K | $262K | $3.78 | 02 May 2022 | Direct |
| Silverback Therapeutics, Inc. | Chief Financial Officer | Stock Option (right to buy) | 87.4K | 02 May 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SPRY | Silverback Therapeutics, Inc. | 02 May 2022 | 2 | $0 | 4 | Chief Financial Officer | 04 May 2022, 17:16 |
| SPRY | Silverback Therapeutics, Inc. | 01 Feb 2022 | 3 | $0 | 4 | Chief Financial Officer | 02 Feb 2022, 16:19 |